Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Scientific Reports|June 5, 2021
Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patientsAlice Courties, Jeremy Boussier, Jérôme Hadjadj, et al.Nature Immunology|February 20, 2019
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growthClémence Hollande, Jeremy Boussier, James Ziai, et al.The Journal of Allergy and Clinical Immunology|November 20, 2021
Severe COVID-19 is associated with hyperactivation of the alternative complement pathwayJeremy Boussier, Nader Yatim, Armance Marchal, et al.Annals of Intensive Care|July 17, 2021
Platelet activation in critically ill COVID-19 patientsNader Yatim, Jeremy Boussier, Richard Chocron, et al.Cell Reports|June 29, 2022
Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activationCeline Posseme, Alba Llibre, Bruno Charbit, et al.Angiogenesis|May 28, 2020
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patientsDavid M Smadja, Coralie L Guerin, Richard Chocron, et al.Elife|November 17, 2015
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patientsCécile Alanio, Francesco Nicoli, Philippe Sultanik, et al.Science Advances|August 19, 2021
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infectionNader Yatim, Jeremy Boussier, Pauline Tetu, et al.Science (New York, N.Y.)|July 15, 2020
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patientsJérôme Hadjadj, Nader Yatim, Laura Barnabei, et al.Nature Communications|January 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Céline Possémé, Marie Templé, et al.Pageof 3